Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 20, 2025, titled "Strides receives USFDA approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg, Expanding the Existing OTC Portfolio.".
Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 20, 2025, titled "Strides receives USFDA approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg, Expanding the Existing OTC Portfolio.".